Results 121 to 130 of about 1,493,759 (300)

UEG's prospects for the future: Strategic plan 2023-2026. [PDF]

United European Gastroenterol J, 2022
Cortez-Pinto H, van Hooft J, Koletzko B, Löhr JM.   +3 more
europepmc   +1 more source

Musselman Library Strategic Plan 2013-2016

, 2013
Musselman Library Strategic Plan 2013-2016 reflects the evolution of libraries and higher education since the 2007 adoption of Crossroads, Connections, and Creativity: Musselman Library Strategic Plan.
Musselman Library,
core  

2008-2012 strategic plan [PDF]

, 2008
12 pp. Bookmarks supplied by UO. Illus. Published February 2008. Captured September 8, 2009.This Plan is anchored by five Strategies that will guide our work and financial investments over the next five years. 1.
Portland (Or.), Portland Development Commission   +1 more
core  

PARP inhibitors elicit distinct transcriptional programs in homologous recombination competent castration‐resistant prostate cancer

Molecular Oncology, EarlyView.
PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham, Jasibel Vasquez‐Gonzalez, Samantha M. Barnada, Salome Tchotorlishvili, Latese Jones, Ryan Maguire, Genevieve Lewis, Kinza Rizwan, Jenny Deng, Salma Koachar, Drithi Patel, Hailey Shankle, Tessa Mulders, Namra Ajmal, Charalambos Solomides, Emad S. Alnemri, Teresa F. Alnemri, Ayesha A. Shafi, Leonard G. Gomella, Wm Kevin Kelly, Steven B. McMahon, Matthew J. Schiewer   +21 more
wiley   +1 more source

Characterizing the salivary RNA landscape to identify potential diagnostic, prognostic, and follow‐up biomarkers for breast cancer

Molecular Oncology, EarlyView.
This study explores salivary RNA for breast cancer (BC) diagnosis, prognosis, and follow‐up. High‐throughput RNA sequencing identified distinct salivary RNA signatures, including novel transcripts, that differentiate BC from healthy controls, characterize histological and molecular subtypes, and indicate lymph node involvement.
Nicholas Rajan, Irina Primac, Emre Etlioglu, Laurens Debruyne, Ann Janssen, Magy Sallam, Kevin Tabury, Roel Quintens, Wiebren Tjalma, Mohammed Abderrafi Benotmane   +9 more
wiley   +1 more source

Soybean Genomics Research Program Strategic Plan

The Plant Genome, 2011
Roger Boerma, Richard Wilson, Ed Ready
doaj   +1 more source

Does India's Zero by 30 Strategic Plan Need the Addition of the Rabies Vaccine to the Universal Immunisation Programme? [PDF]

Health Serv Insights, 2023
Mukhida S, Das NK, Palal D, Verma P, Johnson S.   +4 more
europepmc   +1 more source

Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology

Molecular Oncology, EarlyView.
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts, Senada Koljenović, Elise Daems, Karolien De Wael, Marc Peeters, Léon C. van Kempen, Greetje Vanhoutte, Karen Zwaenepoel, Timon Vandamme   +8 more
wiley   +1 more source

NIDCD's 5-Year Strategic Plan Describes Scientific Priorities and Commitment to Basic Science. [PDF]

J Assoc Res Otolaryngol, 2023
Tucci DL.
europepmc   +1 more source

THE FIRM’S PATRIMONY – AN INTERNATIONAL APPROACH [PDF]

The organization environment is characterized by uncertainty and risk that have an important impact of strategic management. In order to face this problem the managers need to plan their strategies. A useful tool in strategic planning is forecasting, but
Elena DOVAL
core